Trial Details
UNKNOWNBasic Information
| Clinical ID | c4541 |
|---|---|
| Identifier | NCT00353756 |
| Trial Title | Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: C326, IL-6 Inhibitory Avimer protein |
Participant Information
| Sponsor | Avidia |
|---|---|
| City | Queensland |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2006-09 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2007-09 |